:format(webp)/cdn.mskdoctors.com/storage/2026/8/iVkAeySfTXIy2JOZ11BErGf2bexg8dSF.jpg)
ChondroFiller injection for knee cartilage defectsThe injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/vNCi96GKsIqumCyCvktpmNJ3BOdnKcgE.jpg)
Ultrasound-Guided ChondroFiller for Hip Cartilage DefectsAn injectable collagen scaffold recruits the patient's own cells to repair hip cartilage defects; clinical cohorts report 70–85% achieve meaningful symptom relief at 3–5 years, though success requires absence of pre-existing moderate-to-severe osteoarthritis.An injectable collagen scaffold recruits the patient's own cells to repair hip cartilage defects; clinical cohorts report 70–85% achieve meaningful symptom relief at 3–5 years, though success requires absence of pre-existing moderate-to-severe osteoarthritis.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Cg7O8ogHM5wTH3wnxDZ2ERsKT3Yy2FRu.jpg)
ChondroFiller injection for talar osteochondral lesionsAn ultrasound-guided collagen scaffold injected in clinic, ChondroFiller recruits the patient's own progenitor cells to repair focal cartilage defects on the talar dome that persist despite at least six months of conservative care.An ultrasound-guided collagen scaffold injected in clinic, ChondroFiller recruits the patient's own progenitor cells to repair focal cartilage defects on the talar dome that persist despite at least six months of conservative care.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Tc7BZVSZxTAg9ngXUcrH97k20o8iK8T0.jpg)
ChondroFiller injection versus cartilage surgeryChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/fI1OLTY4rXZmoPULfTGjujCUV9qyYume.jpg)
What separates ChondroFiller from Liquid CartilageChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/YhFnfO9lzvEXOlGlxEL9EE2JKrJyBfB0.jpg)
ChondroFiller injection safety and the questions to askChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/qaIZGeooLUJtaK5Ndmgn8681psd7lMhV.jpg)
ChondroFiller versus hyaluronic acid for cartilage defectsChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/d2sjEtq7XNR1pNx8JfjeTUjFQ8U4nAB8.jpg)
ChondroFiller NHS status and private access routesChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Pkn5jqdtOy84Y0P8BuXTi7gRKqCVS9mh.jpg)
ChondroFiller for TMJ cartilage defectsChondroFiller, an injectable collagen scaffold that recruits cartilage-forming cells, shows functional improvements in small-joint cartilage structurally similar to the TMJ, but remains an emerging, untested application for the jaw.ChondroFiller, an injectable collagen scaffold that recruits cartilage-forming cells, shows functional improvements in small-joint cartilage structurally similar to the TMJ, but remains an emerging, untested application for the jaw.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/K6s6v5ayT3GfYYWAcb0fIGhf69xMgqZH.jpg)
What IKDC and MOCART scores mean after ChondroFillerIKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.IKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/9Hqd2xvHBuvx5OPeQiMHYCExN1B2atBZ.jpg)
ChondroFiller injection for ankle cartilage defectsChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.ChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/qK5QIjTamPhwMv8E9NkiBLXaSBf3Bofl.jpg)
ChondroFiller for focal knee defects versus early osteoarthritisFocal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.
